NDC product
Abiraterone Acetate
NDC 0904-6948 · Major Pharmaceuticals
Key facts
| Product NDC | 0904-6948 |
|---|---|
| Proprietary name | Abiraterone Acetate |
| Nonproprietary name | Abiraterone Acetate |
| Substances | ABIRATERONE ACETATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Major Pharmaceuticals |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA208453 |
| Pharmacologic classes | Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA] |
| Marketing start | Nov 23, 2018 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: